GSK: story ‘unfair'

Share this article:
GlaxoSmithKline's director of CME took exception with a Wall Street Journal report on GSK-funded med ed.

The December 2006 article asserts that GSK paid for a series of lectures by doctors who favor universal screening and treatment of pregnant women for genital herpes (MM&M, January 2007), two contentious issues.

“Your article implies that the industry uses [CME] as a means to promote product; this unfairly taints the value that quality CME brings to healthcare professionals and to the patients,” wrote Bryan King, PharmD, director, GSK Center for Medical Education, in a letter to the editor.
GSK's Valtrex is not approved to prevent neonatal herpes in pregnant women.

Share this article:

Email Newsletters

More in News

Meaningful use not linked to quality: study

Meaningful use not linked to quality: study

A recent study of physicians found no correlation between following EHR meaningful use requirements and providing consistently higher quality of care.

Lilly Q1 sales dip

Lilly Q1 sales dip

US sales fell 34% during the quarter, largely due to lower demand and lower prices for off-patent Cymbalta and Evista.

Gilead reaps huge HCV sales, payer fury

Gilead reaps huge HCV sales, payer fury

Sovaldi's debut has been marked by plenty of criticism from payers and lawmakers, but the hep. C drug's launch, now confirmed to be the fastest of all time, has also ...